Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.4 USD | -3.15% | +1.43% | +17.40% |
04:15pm | Oppenheimer Adjusts IDEAYA Biosciences Price Target to $53 From $50, Maintains Outperform Rating | MT |
05-07 | IDEAYA Biosciences Shares Fall After Q1 Loss | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.40% | 3.2B | |
+23.30% | 46.4B | |
-1.16% | 41.75B | |
+47.92% | 41.37B | |
-3.52% | 29.71B | |
+10.55% | 26.01B | |
-19.70% | 19.52B | |
+30.93% | 12.43B | |
+0.16% | 12.18B | |
-0.14% | 12.13B |
- Stock Market
- Equities
- IDYA Stock
- News IDEAYA Biosciences, Inc.
- RBC Raises Price Target on IDEAYA Biosciences to $53 From $43 on 'Clarity & Confidence on Daro's Potential,' Keeps Outperform Rating, Speculative Risk